BACKGROUND: Frontotemporal dementia (FTD) is a complex disorder characterised by a broad range of clinical manifestations, differential pathological signatures, and genetic variability. Mutations in three genes-MAPT, GRN, and C9orf72--have been associated with FTD. We sought to identify novel genetic risk loci associated with the disorder. METHODS: We did a two-stage genome-wide association study on clinical FTD, analysing samples from 3526 patients with FTD and 9402 healthy controls. To reduce genetic heterogeneity, all participants were of European ancestry. In the discovery phase (samples from 2154 patients with FTD and 4308 controls), we did separate association analyses for each FTD subtype (behavioural variant FTD, semantic dementia, progressive non-fluent aphasia, and FTD overlapping with motor neuron disease [FTD-MND]), followed by a meta-analysis of the entire dataset. We carried forward replication of the novel suggestive loci in an independent sample series (samples from 1372 patients and 5094 controls) and then did joint phase and brain expression and methylation quantitative trait loci analyses for the associated (p<5 × 10(-8)) single-nucleotide polymorphisms. FINDINGS: We identified novel associations exceeding the genome-wide significance threshold (p<5 × 10(-8)). Combined (joint) analyses of discovery and replication phases showed genome-wide significant association at 6p21.3, HLA locus (immune system), for rs9268877 (p=1·05 × 10(-8); odds ratio=1·204 [95% CI 1·11-1·30]), rs9268856 (p=5·51 × 10(-9); 0·809 [0·76-0·86]) and rs1980493 (p value=1·57 × 10(-8), 0·775 [0·69-0·86]) in the entire cohort. We also identified a potential novel locus at 11q14, encompassing RAB38/CTSC (the transcripts of which are related to lysosomal biology), for the behavioural FTD subtype for which joint analyses showed suggestive association for rs302668 (p=2·44 × 10(-7); 0·814 [0·71-0·92]). Analysis of expression and methylation quantitative trait loci data suggested that these loci might affect expression and methylation in cis. INTERPRETATION: Our findings suggest that immune system processes (link to 6p21.3) and possibly lysosomal and autophagy pathways (link to 11q14) are potentially involved in FTD. Our findings need to be replicated to better define the association of the newly identified loci with disease and to shed light on the pathomechanisms contributing to FTD.

Frontotemporal dementia and its subtypes: a genome-wide association study.

RAINERO, Innocenzo;RUBINO, Elisa;PINESSI, Lorenzo;
2014-01-01

Abstract

BACKGROUND: Frontotemporal dementia (FTD) is a complex disorder characterised by a broad range of clinical manifestations, differential pathological signatures, and genetic variability. Mutations in three genes-MAPT, GRN, and C9orf72--have been associated with FTD. We sought to identify novel genetic risk loci associated with the disorder. METHODS: We did a two-stage genome-wide association study on clinical FTD, analysing samples from 3526 patients with FTD and 9402 healthy controls. To reduce genetic heterogeneity, all participants were of European ancestry. In the discovery phase (samples from 2154 patients with FTD and 4308 controls), we did separate association analyses for each FTD subtype (behavioural variant FTD, semantic dementia, progressive non-fluent aphasia, and FTD overlapping with motor neuron disease [FTD-MND]), followed by a meta-analysis of the entire dataset. We carried forward replication of the novel suggestive loci in an independent sample series (samples from 1372 patients and 5094 controls) and then did joint phase and brain expression and methylation quantitative trait loci analyses for the associated (p<5 × 10(-8)) single-nucleotide polymorphisms. FINDINGS: We identified novel associations exceeding the genome-wide significance threshold (p<5 × 10(-8)). Combined (joint) analyses of discovery and replication phases showed genome-wide significant association at 6p21.3, HLA locus (immune system), for rs9268877 (p=1·05 × 10(-8); odds ratio=1·204 [95% CI 1·11-1·30]), rs9268856 (p=5·51 × 10(-9); 0·809 [0·76-0·86]) and rs1980493 (p value=1·57 × 10(-8), 0·775 [0·69-0·86]) in the entire cohort. We also identified a potential novel locus at 11q14, encompassing RAB38/CTSC (the transcripts of which are related to lysosomal biology), for the behavioural FTD subtype for which joint analyses showed suggestive association for rs302668 (p=2·44 × 10(-7); 0·814 [0·71-0·92]). Analysis of expression and methylation quantitative trait loci data suggested that these loci might affect expression and methylation in cis. INTERPRETATION: Our findings suggest that immune system processes (link to 6p21.3) and possibly lysosomal and autophagy pathways (link to 11q14) are potentially involved in FTD. Our findings need to be replicated to better define the association of the newly identified loci with disease and to shed light on the pathomechanisms contributing to FTD.
2014
13
7
686
699
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112126/
Ferrari R;Hernandez DG;Nalls MA;Rohrer JD;Ramasamy A;Kwok JB;Dobson-Stone C;Brooks WS;Schofield PR;Halliday GM;Hodges JR;Piguet O;Bartley L;Thompson E;Haan E;Hernández I;Ruiz A;Boada M;Borroni B;Padovani A;Cruchaga C;Cairns NJ;Benussi L;Binetti G;Ghidoni R;Forloni G;Galimberti D;Fenoglio C;Serpente M;Scarpini E;Clarimón J;Lleó A;Blesa R;Waldö ML;Nilsson K;Nilsson C;Mackenzie IR;Hsiung GY;Mann DM;Grafman J;Morris CM;Attems J;Griffiths TD;McKeith IG;Thomas AJ;Pietrini P;Huey ED;Wassermann EM;Baborie A;Jaros E;Tierney MC;Pastor P;Razquin C;Ortega-Cubero S;Alonso E;Perneczky R;Diehl-Schmid J;Alexopoulos P;Kurz A;Rainero I;Rubino E;Pinessi L;Rogaeva E;St George-Hyslop P;Rossi G;Tagliavini F;Giaccone G;Rowe JB;Schlachetzki JC;Uphill J;Collinge J;Mead S;Danek A;Van Deerlin VM;Grossman M;Trojanowski JQ;van der Zee J;Deschamps W;Van Langenhove T;Cruts M;Van Broeckhoven C;Cappa SF;Le Ber I;Hannequin D;Golfier V;Vercelletto M;Brice A;Nacmias B;Sorbi S;Bagnoli S;Piaceri I;Nielsen JE;Hjermind LE;Riemenschneider M;Mayhaus M;Ibach B;Gasparoni G;Pichler S;Gu W;Rossor MN;Fox NC;Warren JD;Spillantini MG;Morris HR;Rizzu P;Heutink P;Snowden JS;Rollinson S;Richardson A;Gerhard A;Bruni AC;Maletta R;Frangipane F;Cupidi C;Bernardi L;Anfossi M;Gallo M;Conidi ME;Smirne N;Rademakers R;Baker M;Dickson DW;Graff-Radford NR;Petersen RC;Knopman D;Josephs KA;Boeve BF;Parisi JE;Seeley WW;Miller BL;Karydas AM;Rosen H;van Swieten JC;Dopper EG;Seelaar H;Pijnenburg YA;Scheltens P;Logroscino G;Capozzo R;Novelli V;Puca AA;Franceschi M;Postiglione A;Milan G;Sorrentino P;Kristiansen M;Chiang HH;Graff C;Pasquier F;Rollin A;Deramecourt V;Lebert F;Kapogiannis D;Ferrucci L;Pickering-Brown S;Singleton AB;Hardy J;Momeni P
File in questo prodotto:
File Dimensione Formato  
GWAS FTLD.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 1.2 MB
Formato Adobe PDF
1.2 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/148710
Citazioni
  • ???jsp.display-item.citation.pmc??? 150
  • Scopus 243
  • ???jsp.display-item.citation.isi??? 243
social impact